Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Jul;54(1):175–181. doi: 10.1172/JCI107739

Immunoreactive Forms of Circulating Parathyroid Hormone in Primary and Ectopic Hyperparathyroidism

Ralph C Benson Jr 1,2, B Lawrence Riggs 1,2, Barbara M Pickard 1,2, Claude D Arnaud 1,2
PMCID: PMC301537  PMID: 4834887

Abstract

The immunoreactive forms of parathyroid hormone (iPTH) in the plasma of six patients with primary, adenomatous hyperparathyroidism and six patients with ectopic hyperparathyroidism due to non-parathyroid cancer were compared by using gel filtration on columns of Bio-Gel P-150 and radioimmunoassay of iPTH in eluted fractions after concentration. We found much less (p<0.001) small (mol wt<9,500) COOH-terminal fragments of iPTH in plasma samples from ectopic hyperparathyroid patients (0.52±0.13 ng eq/ml) than in samples from primary hyperparathyroid patients (3.70±1.15 ng eq/ml). The quantity of iPTH eluting with or before native bovine PTH [1-84] was the same in both syndromes (ectopic hyperparathyroidism, 0.82±0.22 ng eq/ml; primary hyperparathyroidism, 0.73±0.09 ng eq/ml), and these values correlated positively with plasma calcium concentration (ectopic hyperparathyroidism, r=0.908; primary hyperparathyroidism, r=0.919). In both syndromes, plasma samples had an iPTH component that eluted well before PTH [1-84] (mol wt 9,500), but this component was present in much larger quantities in three patients with ectopic hyperparathyroidism. We conclude that (a) the decreased quantity of biologically inactive COOH-terminal fragments of iPTH circulating in ectopic hyperparathyroidism accounts for the previously reported relatively lower total serum iPTH values in this syndrome as compared with primary hyperparathyroidism (Riggs et al. 1971. J. Clin. Invest. 50: 2079); (b) there appears to be sufficient iPTH with presumed biologic activity to account for the hypercalcemia in both syndromes; (c) a large PTH component, not previously recognized in plasma, is present in both ectopic and primary hyperparathyroidism and may exist as the predominant immunoreactive form of the hormone in some patients with ectopic hyperparathyroidism.

Full text

PDF
175

Images in this article

177Image
on p.177
177Image
on p.177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaud C. D. Immunochemical heterogeneity of circulating parathyroid hormone in man: sequel to an original observation by Berson and Yalow. Mt Sinai J Med. 1973 May-Jun;40(3):422–432. [PubMed] [Google Scholar]
  2. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnaud C. D., Tsao H. S., Oldham S. B. Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A. 1970 Sep;67(1):415–422. doi: 10.1073/pnas.67.1.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berson S. A., Yalow R. S. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab. 1968 Jul;28(7):1037–1047. doi: 10.1210/jcem-28-7-1037. [DOI] [PubMed] [Google Scholar]
  5. Blair A. J., Jr, Hawker C. D., Utiger R. D. Ectopic hyperparathyroidism in a patient with metastatic hypernephroma. Metabolism. 1973 Feb;22(2):147–154. doi: 10.1016/0026-0495(73)90265-5. [DOI] [PubMed] [Google Scholar]
  6. Brewer H. B., Jr, Fairwell T., Ronan R., Sizemore G. W., Arnaud C. D. Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3585–3588. doi: 10.1073/pnas.69.12.3585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Canterbury J. M., Levey G. S., Reiss E. Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest. 1973 Feb;52(2):524–527. doi: 10.1172/JCI107211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Canterbury J. M., Reiss E. Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1393–1398. doi: 10.3181/00379727-140-36681. [DOI] [PubMed] [Google Scholar]
  9. Cohn D. V., Macgregor R. R., Chu L. L., Kimmel J. R., Hamilton J. W. Calcemic fraction-A: biosynthetic peptide precursor of parathyroid hormone. Proc Natl Acad Sci U S A. 1972 Jun;69(6):1521–1525. doi: 10.1073/pnas.69.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Habener J. F., Kemper B., Potts J. T., Jr, Rich A. Proparathyroid hormone: biosynthesis by human parathyroid adenomas. Science. 1972 Nov 10;178(4061):630–633. doi: 10.1126/science.178.4061.630. [DOI] [PubMed] [Google Scholar]
  11. Habener J. F., Powell D., Murray T. M., Mayer G. P., Potts J. T., Jr Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A. 1971 Dec;68(12):2986–2991. doi: 10.1073/pnas.68.12.2986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Knill-Jones R. P., Buckle R. M., Parsons V., Calne R. Y., Williams R. Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. N Engl J Med. 1970 Mar 26;282(13):704–708. doi: 10.1056/NEJM197003262821302. [DOI] [PubMed] [Google Scholar]
  13. Lafferty F. W. Pseudohyperparathyroidism. Medicine (Baltimore) 1966 May;45(3):247–260. doi: 10.1097/00005792-196605000-00004. [DOI] [PubMed] [Google Scholar]
  14. Munson P. L., Tashjian A. H., Jr, Levine L. Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia. Cancer Res. 1965 Aug;25(7):1062–1067. [PubMed] [Google Scholar]
  15. Potts J. T., Jr, Niall H. D., Tregear G. W., van Rietschoten J., Habener J. F., Segre G. V., Keutmann H. T. Chemical and biologic studies of proparathyroid hormone and parathyroid hormone: analysis of hormone biosynthesis and metabolism. Mt Sinai J Med. 1973 May-Jun;40(3):448–461. [PubMed] [Google Scholar]
  16. Powell D., Singer F. R., Murray T. M., Minkin C., Potts J. T., Jr Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 1973 Jul 26;289(4):176–181. doi: 10.1056/NEJM197307262890403. [DOI] [PubMed] [Google Scholar]
  17. Reiss E., Canterbury J. M., Egdahl R. H. Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians. 1968;81:104–115. [PubMed] [Google Scholar]
  18. Riggs B. L., Arnaud C. D., Reynolds J. C., Smith L. H. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest. 1971 Oct;50(10):2079–2083. doi: 10.1172/JCI106701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Roof B. S., Carpenter B., Fink D. J., Gordan G. S. Some thoughts on the nature of ectopic parathyroid hormones. Am J Med. 1971 May;50(5):686–691. doi: 10.1016/0002-9343(71)90124-0. [DOI] [PubMed] [Google Scholar]
  20. Segre G. V., Habener J. F., Powell D., Tregear G. W., Potts J. T. Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. J Clin Invest. 1972 Dec;51(12):3163–3172. doi: 10.1172/JCI107143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sherwood L. M., O'Riordan J. L., Aurbach G. D., Potts J. T., Jr Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab. 1967 Jan;27(1):140–146. doi: 10.1210/jcem-27-1-140. [DOI] [PubMed] [Google Scholar]
  22. Sherwood L. M., Rodman J. S., Lundberg W. B. Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1631–1638. doi: 10.1073/pnas.67.3.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Silverman R., Yalow R. S. Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J Clin Invest. 1973 Aug;52(8):1958–1971. doi: 10.1172/JCI107380. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES